Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,154 | 57 | 96.2% |
| Education | $45.41 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $234.29 | 11 | $0 (2022) |
| Amgen Inc. | $155.48 | 8 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $127.41 | 7 | $0 (2023) |
| Boston Scientific Corporation | $100.90 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $99.63 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $97.06 | 5 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $96.02 | 4 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $65.41 | 2 | $0 (2022) |
| Mallinckrodt LLC | $41.99 | 3 | $0 (2018) |
| Aurinia Pharma U.S., Inc. | $24.92 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.25 | 3 | AKEBIA THERAPEUTICS INC ($29.34) |
| 2023 | $53.75 | 3 | Otsuka America Pharmaceutical, Inc. ($20.86) |
| 2022 | $280.17 | 13 | Alexion Pharmaceuticals, Inc. ($65.41) |
| 2021 | $117.23 | 7 | Aurinia Pharma U.S., Inc. ($24.92) |
| 2020 | $36.56 | 2 | Mallinckrodt Hospital Products Inc. ($19.24) |
| 2019 | $228.93 | 12 | OPKO Pharmaceuticals, LLC ($102.28) |
| 2018 | $298.24 | 10 | Boston Scientific Corporation ($100.90) |
| 2017 | $114.32 | 8 | Amgen Inc. ($50.40) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Nephrology | ||||||
| 05/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Inflammation | ||||||
| 01/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardio-renal | ||||||
| 10/11/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $14.61 | General |
| 05/17/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: KRYSTEXXA | ||||||
| 02/23/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: NEPHROLOGY | ||||||
| 11/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 10/03/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Nephrology | ||||||
| 09/16/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/27/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/31/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2022 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $45.41 | General |
| 02/28/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Rare Disease | ||||||
| 02/14/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Nephrology | ||||||
| 01/28/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Nephrology | ||||||
| 01/26/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/19/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEPHROLOGY | ||||||
| 12/02/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/02/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/04/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/23/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEPHROLOGY | ||||||
| 07/31/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 326 | 473 | $63,544 | $38,855 |
| 2022 | 14 | 841 | 1,472 | $261,163 | $146,164 |
| 2021 | 13 | 997 | 1,717 | $327,981 | $187,767 |
| 2020 | 14 | 1,103 | 1,886 | $441,797 | $207,864 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 186 | $22,320 | $15,143 | 67.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 18 | 18 | $8,676 | $4,799 | 55.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 78 | $6,942 | $4,627 | 66.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 19 | $8,075 | $4,279 | 53.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 47 | $5,687 | $4,196 | 73.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 58 | $4,640 | $2,669 | 57.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,550 | $1,838 | 72.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 22 | $4,246 | $1,181 | 27.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 16 | 16 | $240.00 | $81.28 | 33.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 14 | 14 | $168.00 | $43.54 | 25.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 141 | 192 | $92,544 | $52,264 | 56.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 152 | 474 | $42,186 | $25,309 | 60.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 236 | $28,556 | $18,292 | 64.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 57 | 68 | $28,900 | $15,209 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 183 | $21,960 | $14,106 | 64.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 55 | $10,450 | $5,600 | 53.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 48 | 98 | $18,914 | $5,468 | 28.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $4,660 | $3,027 | 65.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $3,740 | $2,536 | 67.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 42 | $3,360 | $2,068 | 61.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 18 | $2,376 | $1,169 | 49.2% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 11 | 14 | $2,842 | $917.51 | 32.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 25 | 25 | $375.00 | $123.37 | 32.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 25 | 25 | $300.00 | $75.51 | 25.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 224 | 307 | $147,974 | $85,521 | 57.8% |
About Dr. Robert Hoit, MD
Dr. Robert Hoit, MD is a Nephrology healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285638247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hoit, MD has received a total of $1,199 in payments from pharmaceutical and medical device companies, with $70.25 received in 2024. These payments were reported across 58 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,154).
As a Medicare-enrolled provider, Hoit has provided services to 3,267 Medicare beneficiaries, totaling 5,548 services with total Medicare billing of $580,650. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Montgomery, AL
- Active Since 06/08/2005
- Last Updated 02/19/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285638247
Products in Payments
- Rayaldee (Drug) $183.58
- ANGIOJET (Device) $100.90
- Parsabiv (Biological) $97.14
- Velphoro (Drug) $94.49
- LOKELMA (Drug) $82.31
- Auryxia (Drug) $77.94
- ACTHAR (Biological) $61.23
- SAMSCA (Drug) $56.34
- RAYALDEE (Drug) $50.71
- JYNARQUE (Drug) $43.29
- LUPKYNIS (Drug) $24.92
- TAVNEOS (Drug) $23.89
- TARPEYO (Drug) $23.43
- BYSTOLIC (Drug) $22.25
- SOLIRIS (Biological) $20.00
- Dialyzers (Device) $18.31
- KRYSTEXXA (Biological) $18.28
- AURYXIA (Drug) $18.08
- BENLYSTA (Biological) $17.39
- Sensipar (Drug) $17.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Montgomery
Kim Mcglothan, M.d, M.D
Nephrology — Payments: $4,836
Melanie Halvorson, M.d, M.D
Nephrology — Payments: $4,529
Rodney Smith, Md, MD
Nephrology — Payments: $4,414
Dr. Jogy Varghese, M.d, M.D
Nephrology — Payments: $2,411
Dr. Ibrahim El Halabi, Md, MD
Nephrology — Payments: $740.49
Dr. Rakesh Kanipakam, Md, MD
Nephrology — Payments: $656.19